New research published in the journal Brain suggests that people with diabetes who take the medication exenatide may have a lower risk of developing...
A team from the University College London Institute of Neurology, led by Thomas Foltynie, PhD, MD, MRCP, recently published results of an MJFF-funde...
The greatest unmet need of people with Parkinson’s disease is a therapy to slow or stop progression. A treatment to reverse the symptoms would be th...